Oral mucosal Langerhans' cells as target, effector and vector in HIV infection

Journal of Oral Pathology and Medicine

Volumn 29, Issue 8, 2000, Pages 394-402

  Chou, L Lee ^a   Epstein, J ^b   Cassol, S A ^c   West, D M ^a   He, W ^a   Firth, J D ^b  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

HIV infection; Langerhans' cells; Oral hairy leukoplakia

Indexed keywords

CD1 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; CORE PROTEIN; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

AIDS RELATED COMPLEX; ARTICLE; CYTOPATHOGENIC EFFECT; DISEASE PREDISPOSITION; EPITHELIUM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LANGERHANS CELL; LEUKOPLAKIA; MALE; MOUTH MUCOSA; NONPARAMETRIC TEST; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; SERODIAGNOSIS; T LYMPHOCYTE; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD45; ANTIGENS, CD86; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE SUSCEPTIBILITY; EPITHELIAL CELLS; HIV; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HLA-DR ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; LANGERHANS CELLS; LEUKOPLAKIA, HAIRY; MALE; MEMBRANE GLYCOPROTEINS; MOUTH MUCOSA; PHENOTYPE; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; VIRAL CORE PROTEINS;

EID: 0033841660     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2000.290805.x     Document Type: Article

References (66)

1. Klatzman D, Barre-Sinoussi F, Nugeyre MT, et al. Selective tropism of lymphoadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 1984; 225: 59-63.
2. Gartner S, Markovitz P, Markovitz DM, et al. The role of mononuclear phagocytes in HTLV III/LAV infection. Science 1986; 233: 215-9.
3. Tschachler E, Groh V, Popovic M, et al. Epidermal Langerhans cells - a target for HTLV-III/LAV infection. J Invest Dermatol 1987; 88: 233-7.
4. Rappersberger K, Gartner S, Schenk P, et al. Langerhans cells are an actual site of HIV-1 replication. Intervirology 1988; 29: 185-94.
5. Qureshi MN, Barr CE, Seshamman T, et al. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J Infect Dis 1995; 71: 190-3.
6. Chou L, Boustany F, Nathanson D, et al. G to A hypermutation in env loop V2 region of HIV-1 gene in oral hairy leukoplakia. J Dent Res 1996; 75: 115.
7. Streilein JW. Lymphocyte traffic, T-cell malignancies and the skin. J Invest Dermatol 1978; 71: 167-71.
8. Chu T, Jaffe R. The normal Langerhans cell and the LCH cell (Review). Br J Cancer 1994; 23: S4-S10.
9. Yu RCH, Morris JF, Pritchard J, et al. Defective alloantigen-presenting capacity of Langerhans cell histocytosis cells. Arch Dis Child 1992; 67: 1370-2.
10. Macatonia SE, Knight SC, Edwards AJ, et al. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 1987; 166: 1654-67.
11. Kupiec-Weglinski JW, Austin JW, Morris PJ. Migration patterns of dendritic cells in the mouse. Traffic from blood, and T cell-dependent and independent entry to lymphoid tissues. J Exp Med 1988; 167: 632-3.
12. Wood GS, Warber NL, Warner RA. Anti-Leu-3/T4 antibodies react with cells of monocyte, macrophage and Langerhans lineage. J Immunol 1983; 131: 212-6.
13. Wolff K, Stingl G. The Langerhans cell. J Invest Dermatol 1983; 80 (suppl): 17s-21s.
14. Groh V, Tani M, Harrer A, et al. Leu-3/T4 expression on epidermal Langerhans cells in normal and diseased skin. J Invest Dermatol 1986; 86: 115-20.
15. Greenspan D, Greenspan JS, Pindborg JJ, et al. AIDS and the dental team. Copenhagen: Munksgaard, 1986.
16. Greenspan JS, Greenspan D. Oral hairy leukoplakia: diagnosis and management (Review). Oral Surg Oral Med Oral Pathol 1989; 67: 396-403.
17. Fithian E, Kung P, Goldstein G, et al. Reactivity of Langerhans cells with hybridoma antibody. Proc Natl Acad Sci USA 1981; 78: 2541-4.
18. McMichael AJ, Pilch JR, Galfre G, et al. A human thymacyte antigen defined by a hybrid myeloma monoclonal antibody. Bur J Immunol 1979; 9: 205-10.
19. Daniels TE, Chou L, Greenspan JS, et al. Reduction of Langerhans cells in smokeless tobacco-associated oral mucosal lesions. J Oral Pathol Med 1991; 21: 100-4.
20. Daniels TE. Human mucosal Langerhans cells: postmortem identification of regional variations in oral mucosa. J Invest Dermatol 1984; 82: 8221-24.
21. Wong-Staal F, Sadaie MR. The control of human retrovirus gene expression. Franza BR, et al., eds. Cold Spring Harbor Press, 1988: 1-10.
22. Veronese FD, Copeland TD, Oroszlan S, et al. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J Virol 1988; 62: 795-801.
23. Chou L, Firth JD, Uitto V-J, et al. Substratum surface topography alters cell shape and regulates fibronectin mRNA level, mRNA stability, secretion and assembly in human fibroblasts. J Cell Sci 1995; 108: 1563-73.
24. Oakley C, Brunette DM. The sequence of alignment of microtubules, focal contacts and actin filaments in fibroblasts spreading on smooth and grooved titanium substrata. J Cell Sci 1993; 106: 343-54.
25. Ohki O, Yokozeki H, Katayama I. Functional CD86 (B7-2/B70) 9s predominantly expressed on Langerhans cells in atopic dermatitis. Br J Dermatol 1997; 136: 838-845.
26. Yokozeki H, Takayama K, Ohki O, et al. Comparative analysis of CD86 on human Langerhans cells: expression and function. Arch Dermatol Res 1998; 290: 547-52.
27. Yokozeki H, Takayama K, Ohki O, et al. Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells. Br J Dermatol 1997; 136: 831-7.
28. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233-58.
29. Akbar AN, Terry L, Timms A, et al. Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. J Immunol 1988; 140: 2171-8.
30. Sanders ME, Makgoba MW, Sharrow SO, et al. Human memory lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHLI, CDw29, and Pgp-1) and have enhanced IFN-r production. J Immunol 1988; 140: 1401-7.
31. Pope M, Betjes MGH, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994; 78: 389-98.
32. Silverman S, Migliorati CA, Lozada-Nur F, et al. Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males. J Am Dent Assoc 1986; 112: 187-92.
33. Pindborg JJ. Classification of oral lesions associated with HIV infection (Review). Oral Surg Oral Med Oral Pathol 1989; 67: 292-5.
34. Sixbey JW, Nedrud JG, Raab-Traub N, et al. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984; 310: 1225-30.
35. Vaishnav YN, Wong-Staal F. The biochemistry of AIDS (Review). Annu Rev Biochem 1991; 60: 577-630.
36. Kim S, Byrn R, Groopman J, Baltimore D. Temporal aspects of DNA and RNA synthesis during HIV infection: evidence for differential gene expression. J Virol 1989; 63: 3708-13.
37. Cassol S, Estable M, Mo T, et al. New insight into HIV-1 replication and transmission: implications for therapeutic intervention. Can Assoc Clin Micro Inf Dis 1994; 9: 3-4.
38. Cullen BR, Green WC. Regulation pathways governing HIV-1 replication (Review). Cell 1989; 58: 423-6.
39. Feinberg MB, Jarett RF, Aldovini A, et al. HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell 1986; 46: 807-17.
40. Sodroski J, Goh WC, Rosen C, et al. A second post-transcriptional transactivator gene required for HIV-III replication. Nature 1986; 321:412-7.
41. Shotton C, Arnold C, Sattentan Q, et al. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the HIV-1 envelope. J Virol 1995; 69: 222-30.
42. Borman AM, Quillent C, Charneau P, et al. A high detective HIV-1 group of provirus: evidence for the role of local sequence determinants in G→A hypermutation during negative-strand viral DNA synthesis. Virology 1996; 208: 601-9.
43. Vartanian J, Meyerhans A, Asjo B, et al. Selective, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J Virol 1991; 65: 1779-88.
44. Stingl G, Rappersberger K, Tschacher E, et al. Langerhans cells and HIV-1 infection. J Am Acad Dermatol 1990; 22: 1210-7.
45. Blauvelt A, Katz SI. The skin as target, vector, and effector organ in human immunodeficiency virus disease. J Invest Dermatol 1995: 105: 122s-6s.
46. Shah PD, Gilbertson SM, Rowley DA. Dendritic cells that have interacted with antigen are targets for natural killer cells. J Exp Med 1985; 162: 625-36.
47. Knight SC, Askonas BA, Macatonia SE. Dendritic cells as targets for cytotoxic T lymphocytes. Adv Exp Med Biol 1995; 417: 389-94.
48. Daniels TE, Greenspan D, Greenspan JS, et al. Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion. J Invest Dermatol 1987; 89: 178-82.
49. Dreno B, Milpied B, Bignon JD, et al. Prognostic value of Langerhans cells in the epidermis of HIV patients. Br J Dermatol 1988; 118: 481-6.
50. Zemelman V, Van Neer F, Roberts N, et al. Epidermal Langerhans cells, HIV-1 infection and psoriasis. Br J Dermatol 1994; 130: 307-11.
51. Kanitakis J, Marchand C, Su H, et al. Immunohistochemical study of normal skin of HIV-infected patients shows no evidence of infection of epidermal Langerhans cells by HIV. AIDS Res Hum Retroviruses 1989; 5: 293-302.
52. Kalter DC, Greenhouse JJ, Orenstein JM, et al. Epidermal Langerhans cells are not principal reservoirs of virus in HIV diseases. J Immunol 1991; 146: 3396-404.
53. Blauvelt A, Clerici M, Lucey DR, et al. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol 1995; 154: 3506-15.
54. Misery L, Campos L, Dezutter-Dambuyant C, et al. CD1-reactive leukemic cells in bone marrow: presence of Langerhans cell marker on leukemia monocytic cells. Eur J Haematol 1992; 48: 27-32.
55. Ramael M, Colebunders R, Colpaert C, et al. The prevalence of hairy leukoplakia in HIV seropositive and HIV seronegative immunocompromised patients. Int J STD AIDS 1992; 3: 251-4.
56. Schiodt M, Bakilana PB, Hiza JF, et al. Oral candidiasis and hairy leukoplakia correlated with HIV infection in Tanzania. Oral Surg Oral Med Oral Pathol 1990; 69: 591-6.
57. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 1991; 5: 519-25.
58. Greenspan D. Treatment of oral candidiasis in HIV infection (Review). Oral Surg Oral Med Oral Pathol 1994; 78; 211-5.
59. Zambruno G, Mori L, Marconi A, et al. Detection of HIV in epidermal Langerhans cells of HIV-infected patients using the polymerase chain reaction. J Invest Dermatol 1991; 96: 979-82.
60. Giannetti A, Zambruno G, Cimarelli A, et al. Direct detection of HIV RNA in epidermal Langerhans cells of HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1993; 6: 329-33.
61. Henry M, Uthman A, Ballam C, et al. Epidermal Langerhans cells of AIDS patients express HIV-1 regulatory and structural genes. J Invest Dermatol 1994; 103: 593-6.
62. Steinman R, Hoffman L, Pope M. Maturation and migration of cutaneous dendritic cells. J Invest Dermatol 1995; 105: 2S-7S.
63. Steinman RM, Pack M, Inaba K. Dendritic cell development and maturation. Adv Exp Med Biol 1995; 417: 1-6.
64. Pecker LJ, Kishimoto TK, Smith CW, et al. Elam-1 is an adhesion molecule for skin-homing T cells. Nature 1991; 349: 796-9.
65. Zambruno G, Giannetti A, Bertazzoni U, et al. Langerhans cells and HIV infection. Immunol Today 1995; 26: 520-4.
66. Zambruno G, Girolomoni G, Re MC, et al. In vitro infection of human epidermal Langerhans cells with human immunodeficiency virus type-1. Adv Exp Med Biol 1995; 417: 453-5.